Cancer Research UK, headquartered in Great Britain, is a leading charity dedicated to advancing cancer research and improving patient outcomes. Founded in 2002, it has become a pivotal force in the fight against cancer, funding groundbreaking research and supporting innovative treatments across the UK and beyond. With a focus on prevention, diagnosis, and treatment, Cancer Research UK operates in various regions, collaborating with universities, hospitals, and research institutions. Its unique approach combines scientific expertise with public engagement, making it a trusted authority in oncology. Notable achievements include significant contributions to cancer survival rates and the development of life-saving therapies. As a prominent player in the cancer research sector, Cancer Research UK continues to lead initiatives that transform the landscape of cancer care, ensuring that advancements benefit patients and their families.
How does Cancer Research UK's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Membership Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cancer Research UK's score of 26 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cancer Research UK currently does not have any publicly available emissions data for the most recent year, nor does it report specific carbon emissions figures in kg CO2e. The organisation has not outlined any formal reduction targets or commitments through initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. As of now, there are no details regarding emissions inherited from a parent or related organisation, indicating that Cancer Research UK operates independently in this regard. The absence of specific emissions data and reduction initiatives suggests a need for further transparency and commitment to climate action within the organisation.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cancer Research UK has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
